Involvement of Cxcl12a/Cxcr4b Chemokine System in Mediating the Stimulatory Effect of Embryonic Ethanol Exposure on Neuronal Density in Zebrafish Hypothalamus.

Autor: Collier AD; From the, Laboratory of Behavioral Neurobiology, The Rockefeller University, New York, New York., Khalizova N; From the, Laboratory of Behavioral Neurobiology, The Rockefeller University, New York, New York., Chang GQ; From the, Laboratory of Behavioral Neurobiology, The Rockefeller University, New York, New York., Min S; From the, Laboratory of Behavioral Neurobiology, The Rockefeller University, New York, New York., Campbell S; From the, Laboratory of Behavioral Neurobiology, The Rockefeller University, New York, New York., Gulati G; From the, Laboratory of Behavioral Neurobiology, The Rockefeller University, New York, New York., Leibowitz SF; From the, Laboratory of Behavioral Neurobiology, The Rockefeller University, New York, New York.
Jazyk: angličtina
Zdroj: Alcoholism, clinical and experimental research [Alcohol Clin Exp Res] 2020 Dec; Vol. 44 (12), pp. 2519-2535. Date of Electronic Publication: 2020 Nov 16.
DOI: 10.1111/acer.14482
Abstrakt: Background: Embryonic exposure to ethanol (EtOH) produces marked disturbances in neuronal development and alcohol-related behaviors, with low-moderate EtOH doses stimulating neurogenesis without producing apoptosis and high doses having major cytotoxic effects while causing gross morphological abnormalities. With the pro-inflammatory chemokine system, Cxcl12, and its main receptor Cxcr4, known to promote processes of neurogenesis, we examined here this neuroimmune system in the embryonic hypothalamus to test directly if it mediates the stimulatory effects low-moderate EtOH doses have on neuronal development.
Methods: We used the zebrafish (Danio rerio) model, which develops externally and allows one to investigate the developing brain in vivo with precise control of dose and timing of EtOH delivery in the absence of maternal influence. Zebrafish were exposed to low-moderate EtOH doses (0.1, 0.25, 0.5% v/v), specifically during a period of peak hypothalamic development from 22 to 24 hours postfertilization, and in some tests were pretreated from 2 to 22 hpf with the Cxcr4 receptor antagonist, AMD3100. Measurements in the hypothalamus at 26 hpf were taken of cxcl12a and cxcr4b transcription, signaling, and neuronal density using qRT-PCR, RNAscope, and live imaging of transgenic zebrafish.
Results: Embryonic EtOH exposure, particularly at the 0.5% dose, significantly increased levels of cxcl12a and cxcr4b mRNA in whole embryos, number of cxcl12a and cxcr4b transcripts in developing hypothalamus, and internalization of Cxcr4b receptors in hypothalamic cells. Embryonic EtOH also caused an increase in the number of hypothalamic neurons and coexpression of cxcl12a and cxcr4b transcripts within these neurons. Each of these stimulatory effects of EtOH in the embryo was blocked by pretreatment with the Cxcr4 antagonist AMD3100.
Conclusions: These results provide clear evidence that EtOH's stimulatory effects at low-moderate doses on the number of hypothalamic neurons early in development are mediated, in part, by increased transcription and intracellular activation of this chemokine system, likely due to autocrine signaling of Cxcl12a at its Cxcr4b receptor within the neurons.
(© 2020 by the Research Society on Alcoholism.)
Databáze: MEDLINE
Externí odkaz: